Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Igor Dmitriev"'
Autor:
Whitney C. Weber, Takeshi F. Andoh, Craig N. Kreklywich, Zachary J. Streblow, Michael Denton, Magdalene M. Streblow, John M. Powers, Gauthami Sulgey, Samuel Medica, Igor Dmitriev, David T. Curiel, Nicole N. Haese, Daniel N. Streblow
Publikováno v:
Vaccines, Vol 12, Iss 9, p 970 (2024)
Chikungunya virus (CHIKV) is a pathogenic arthritogenic alphavirus responsible for large-scale human epidemics for which a vaccine was recently approved for use. Mayaro virus (MAYV) is a related emerging alphavirus with epidemic potential with circul
Externí odkaz:
https://doaj.org/article/a5c3ecbf3e444fc38d200d6716b2545d
Autor:
Rebecca M. Broeckel, Nicole Haese, Takeshi Ando, Igor Dmitriev, Craig N. Kreklywich, John Powers, Michael Denton, Patricia Smith, Thomas E. Morrison, Mark Heise, Victor DeFilippis, Ilhem Messaoudi, David T. Curiel, Daniel N. Streblow
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Chikungunya virus (CHIKV) infections can cause severe and debilitating joint and muscular pain that can be long lasting. Current CHIKV vaccines under development rely on the generation of neutralizing antibodies for protection; however, the role of T
Externí odkaz:
https://doaj.org/article/e0f6d6c3c6d84f9c8c83a6a0453541c9
Improved Induction of Anti-Melanoma T Cells by Adenovirus-5/3 Fiber Modification to Target Human DCs
Autor:
Dafni Chondronasiou, Tracy-Jane T. H. D. Eisden, Anita G. M. Stam, Qiana L. Matthews, Mert Icyuz, Erik Hooijberg, Igor Dmitriev, David T. Curiel, Tanja D. de Gruijl, Rieneke van de Ven
Publikováno v:
Vaccines, Vol 6, Iss 3, p 42 (2018)
To mount a strong anti-tumor immune response, non T cell inflamed (cold) tumors may require combination treatment encompassing vaccine strategies preceding checkpoint inhibition. In vivo targeted delivery of tumor-associated antigens (TAA) to dendrit
Externí odkaz:
https://doaj.org/article/68934ed8b0c8421183a3c233f2660b60
Autor:
Jean Mukherjee, Igor Dmitriev, Michelle Debatis, Jacqueline M Tremblay, Gillian Beamer, Elena A Kashentseva, David T Curiel, Charles B Shoemaker
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e106422 (2014)
Current therapies for most acute toxin exposures are limited to administration of polyclonal antitoxin serum. We have shown that VHH-based neutralizing agents (VNAs) consisting of two or more linked, toxin-neutralizing heavy-chain-only VH domains (VH
Externí odkaz:
https://doaj.org/article/bc6802fee7bb482391757d8875eae337
Publikováno v:
Construction and Architecture. 10:41-45
The article examines the creative path of the famous architect Moshe Safdi. The features of his first project - the residential complex “Habitat 67”, consisting of cubic modules that successfully form the composition of the building, are given. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bc81ded5d5faa667bb34f4899d74450
https://doi.org/10.29039/2308-0191-2022-10-3-41-45
https://doi.org/10.29039/2308-0191-2022-10-3-41-45
Autor:
Ronald D. Alvarez, David T. Curiel, Kurt R. Zinn, Gene P. Siegal, Rosemarie Aurigemma, Raymond D. Harris, Meredith A. Preuss, Zhiying You, Souheil Saddekni, Minghui Wang, Janis P. O'Malley, Igor Dmitriev, Kenneth H. Kim
PDF file - 43K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a6885887cd3ad13f74e38ed8dcadc41
https://doi.org/10.1158/1078-0432.22444520.v1
https://doi.org/10.1158/1078-0432.22444520.v1
Autor:
Ronald D. Alvarez, David T. Curiel, Kurt R. Zinn, Gene P. Siegal, Rosemarie Aurigemma, Raymond D. Harris, Meredith A. Preuss, Zhiying You, Souheil Saddekni, Minghui Wang, Janis P. O'Malley, Igor Dmitriev, Kenneth H. Kim
PDF file - 81K, Supplementary Table 2 Primers and probe sets utilized in this study were designed by the Primer Express 1.5 software and synthesized by Sigma-Aldrich. These primers and probes were utilized for quantitative PCR in ancillary biologic s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68ea42add38f13fc2f9e4424c207cc40
https://doi.org/10.1158/1078-0432.22444514
https://doi.org/10.1158/1078-0432.22444514
Autor:
Ronald D. Alvarez, David T. Curiel, Kurt R. Zinn, Gene P. Siegal, Rosemarie Aurigemma, Raymond D. Harris, Meredith A. Preuss, Zhiying You, Souheil Saddekni, Minghui Wang, Janis P. O'Malley, Igor Dmitriev, Kenneth H. Kim
PDF file - 106K, Patients were then assigned into one of three Ad5.SSTR/TK.RGD dose cohorts ranging from 1 x 109 vp/d to 1 x 1012 vp/d (6 x 107 pfu/d to 6 x 1010 pfu/d). This dose administration strategy has been validated in our preclinical studies;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c703bb2ad04fda9ebe48795be95725d
https://doi.org/10.1158/1078-0432.22444523.v1
https://doi.org/10.1158/1078-0432.22444523.v1
Autor:
Ronald D. Alvarez, David T. Curiel, Kurt R. Zinn, Gene P. Siegal, Rosemarie Aurigemma, Raymond D. Harris, Meredith A. Preuss, Zhiying You, Souheil Saddekni, Minghui Wang, Janis P. O'Malley, Igor Dmitriev, Kenneth H. Kim
Purpose: Ad5.SSTR/TK.RGD is an infectivity-enhanced adenovirus expressing a therapeutic thymidine kinase suicide gene and a somatostatin receptor (SSTR) that allows for noninvasive gene transfer imaging. The purpose of this study was to identify the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dac21ac75f9f690a18fa1ff9e5cb393c
https://doi.org/10.1158/1078-0432.c.6520214.v1
https://doi.org/10.1158/1078-0432.c.6520214.v1
Autor:
Ronald D. Alvarez, David T. Curiel, Kurt R. Zinn, Gene P. Siegal, Rosemarie Aurigemma, Raymond D. Harris, Meredith A. Preuss, Zhiying You, Souheil Saddekni, Minghui Wang, Janis P. O'Malley, Igor Dmitriev, Kenneth H. Kim
PDF file - 51K, Patients were then assigned into one of three Ad5.SSTR/TK.RGD dose cohorts ranging from 1 x 109 vp/d to 1 x 1012 vp/d (6 x 107 pfu/d to 6 x 1010 pfu/d). This dose administration strategy has been validated in our preclinical studies;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::373614ca9eed6958b07bedc762f8e6f6
https://doi.org/10.1158/1078-0432.22444517.v1
https://doi.org/10.1158/1078-0432.22444517.v1